Why it matters for patients
Some specific types of cancer can be strongly influenced by genes, breast or prostate cancer for example. The purpose of genetic risk assessment is to identify individuals at elevated cancer risk who may benefit from genetic testing, additional screening or preventive interventions. By listening to patients personal and family stories, you can get several information on their risk to develop cancer. ECPC strongly believes that patients must be informed in order to take an active role in the decision-making concerning their treatment and we have developed this tool to allow patients to do so.
Ecancer in collaboration with the European Cancer Patient Coalition has develop this toolkit to provide patients with a comprehensive resource on genetic testing. Seven interactive modules provide key information and practical advice to support you in making informed decisions. This toolkit is already available in English German, French, Italian and Spanish.
How to make the most of this tool
Go through each of the five e-learning modules in order and test or further increase your knowledge by using the links below to find even more in-depth information on Genetics and Genomics Testing.
We encourage all our visitors to share this e-learning tool with their colleagues. The scope and the content remain the sole responsibility of ecancer and the European Cancer Patient Coalition.